BioPharma
Global CDMO Market for Cell and Gene Therapy Expands Rapidly
During the period of time from 2023 to 2029, the global market for cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services is...
BioPharma
CDMOs Must Reorganize to Maximize Revenue and Competitiveness
Pharmaceutical businesses increasingly outsource their product development and manufacture to Contract Development and manufacture Organizations (CDMOs), which operate in a fragmented sector that is experiencing...
BioPharma
Thermo Fisher to Acquire Clario Holdings for $8.9bn
Thermo Fisher to acquire Clario Holdings, the clinical trial data firm, for $8.9 billion in cash is in news and the same has been announced by...
BioPharma
J&J To Be in Sync with Trump Administration as MFN Spreads
As the two Trump administration drug pricing deals find their place in the books and more that are likely on the way, the U.S. policy...
BioPharma
Investments in the U.S. of Over $70bn Announced by Merck
It is well to be noted that in 2025, a minimum of 14 major pharmaceutical companies across the world went ahead and announced plans to...
BioPharma
LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood
As the U.S. production investments continue to roll in 2025, LTS Lohmann, the German pharmaceutical technology specialist, is joining the table with a deal to...
BioPharma
US Tariffs on Pharma Exports from Singapore Deferred
As originally reported by the Straits Times and also shared by Reuters, the enforcement of US tariffs on pharma exports from Singapore is being deferred so as...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.